TTrialPathMatch Me to Trials
← Back to trials
RecruitingHIV Seropositivity

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

Eligible age

18–49 yrs

Accepts

All genders

Locations

3 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.

Sponsor: University of Chicago

You may qualify if…

  • Aged 18-49 years old, inclusive
  • Speak English
  • Own a cell phone not shared with anyone else
  • Have missed at least one HIV care scheduled visit or have not been virally suppressed in the past 24 months.
  • Resides in Chicagoland, Illinois or Alabama
  • Index agrees to engage the Support Confidant
  • Age 18 years or older
  • Speaks English

You may not qualify if…

  • If a participant fails to meet all inclusion criteria
  • Romantic/Sexual partners of Index participant
  • Relationship strain or abuse present in Index-Support Confidant relationship

Where it's recruiting

Alabama

Birmingham · Huntsville

Illinois

Chicago

Louisiana

New Orleans

Source: ClinicalTrials.gov · NCT05723653 · last updated 2026-04-08

Hybrid Type I Effectiveness-Implementation Trial of a Social Network S · TrialPath